#United States #Chicago #Probiotics #bioMérieux #GENE-UP

BioMérieux Launches Innovative PCR Testing Solution

In today's health-conscious market, the integrity of dietary supplements is paramount. To meet the growing consumer demand for transparency and quality, bioMérieux, a leader in in vitro diagnostics, has launched the groundbreaking GENE-UP® PROBIOTIC SPECIES ID. This pioneering PCR testing solution provides precise species-level identification of probiotics, helping manufacturers ensure the accuracy of their supplement labels in under 90 minutes.

The introduction of this testing solution marks a significant advancement in the area of dietary supplements, especially in a market that is increasingly scrutinizing product claims. Developed in collaboration with NOW®, a respected figure in the natural products sector with over 50 years of experience, this innovation aims to streamline quality control processes for probiotics, which can often involve costly and time-consuming methods.

Understanding the Need for Speed and Precision

The probiotic market has seen unprecedented growth in recent years, fueled in part by rising consumer awareness and demand for high-quality health products. However, this growth has come with challenges. Manufacturers often face the burden of lengthy verification processes that can lead to operational bottlenecks. The traditional methods, characterized by complexity and slow turnaround times, create pressures on quality control teams and can result in delayed product releases, increased holding costs, and the risk of misinformation on labels.

Miguel Villa, Senior Vice President of Industrial Applications at bioMérieux, highlighted how crucial it is for manufacturers to confidently support their products with precise identification. “In the U.S., where the probiotics market continues to grow and consumer scrutiny continues to rise, GENE-UP® PROBIOTIC SPECIES ID gives manufacturers the confidence to stand behind their products and deliver precise species identification that supports label integrity and protects brand reputation.”

The Science Behind GENE-UP® PROBIOTIC SPECIES ID

The GENE-UP® PROBIOTIC SPECIES ID leverages advanced PCR technology to provide rapid results. This allows in-house quality control teams and external laboratory partners to verify up to 18 commonly used probiotic species, including Lactobacillus acidophilus and Bifidobacterium lactis. The efficiency of this solution not only meets the growing industry demand but also reinforces the scientific rigor and operational efficiency required in today's competitive landscape.

Alejo Migones, Senior Vice President of Global Food Safety Quality at bioMérieux, emphasized the necessity for effective testing solutions: “Probiotic manufacturers are navigating a rapidly evolving landscape where ensuring reliable species verification is becoming essential—not only for quality control, but also for minimizing operational risk.”

Bridging the Gap in Quality Control

Prior to the development of GENE-UP®, many companies, including NOW®, relied on third-party laboratories for species identification. This dependence could result in extended waiting times and hindered production schedules. As Maria Mendres, Microbiology Manager at NOW®, noted, the collaboration with bioMérieux has transformed how they approach quality assurance. “Our partnership...gives us the ability to generate accurate, on-site species-level results in 90 minutes or less. That speed not only helps us hit production targets and minimize waste but also strengthens our ability to consistently deliver validated label claims.”

This new solution is not limited to manufacturers; third-party reference laboratories are also adopting the GENE-UP® PROBIOTIC SPECIES ID to enhance their testing capabilities. It offers a standardized approach to species identification, thereby functioning as a complementary option alongside other methods for routine testing and high-throughput screening. This adaptability helps manage increasing sample volumes and allows more complex analytical tasks to be prioritized.

A Commitment to Safety and Trust

As a company founded on a commitment to enhancing patient health and consumer safety, bioMérieux is dedicated to empowering industry leaders through its xPRO™ Program. This initiative connects industry stakeholders directly with bioMérieux experts to accelerate the development of next-generation molecular diagnostics, addressing key quality and safety challenges in the industry.

The GENE-UP® PROBIOTIC SPECIES ID not only underscores bioMérieux's innovative spirit but also highlights its ongoing commitment to advancing the fields of diagnostics and consumer safety within the dietary supplement industry. As this product becomes available in the U.S. with plans for global rollout, it promises to set a new standard for quality assurance in probiotics.

For more information about this revolutionary product, visit bioMérieux's official site.

Conclusion

The launch of GENE-UP® PROBIOTIC SPECIES ID by bioMérieux represents a significant step forward in the world of probiotics, combining speed, accuracy, and efficiency to support manufacturers in delivering safe and reliable health products. This innovation is expected to not only enhance operational efficiencies but also foster greater consumer trust in probiotic claims, paving the way for a more transparent and accountable dietary supplement industry.